Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN   US09061G1013

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
71(c) 74.71(c) 74.32(c) 75.01(c) 81.03(c) Last
855 837 1 559 191 969 831 1 272 468 2 399 260 Volume
+0.78% +5.23% -0.52% +0.93% +8.03% Change
More quotes
Company
BioMarin Pharmaceutical, Inc. develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.The company operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's product portfolio is comprised of... 
Sector
Pharmaceuticals
Calendar
02/19Earnings Release
Surperformance© rating of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More about the company
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 708 M
EBIT 2014 -137 M
Net income 2014 -169 M
Debt 2014 233 M
Yield 2014 -
Sales 2015 871 M
EBIT 2015 -137 M
Net income 2015 -181 M
Debt 2015 298 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 17,3x
EV / Sales 2015 14,1x
Capitalization 11 987 M
More Financials
Latest news on BIOMARIN PHARMACEUTICAL IN
2d ago BIOMARIN PHARMACEUTICAL : beats 3Q profit forecasts
2d ago BIOMARIN PHARMACEUTICAL : Results of Operations and Financial Condition, Financi..
2d ago BIOMARIN PHARMACEUTICAL : Announces Third Quarter 2014 Financial Results
5d ago BIOMARIN PHARMACEUTICAL : Analyst Scanner on Biotech Equities - Amgen, Exelixis,..
10/17DJAmgen Files Patent Infringement Suit Over Cholesterol Drug
10/14 BIOMARIN PHARMACEUTICAL : Change in Directors or Principal Officers, Financial S..
10/08 BIOMARIN PHARMACEUTICAL : to Host Third Quarter 2014 Financial Results Conferenc..
09/24 BIOMARIN PHARMACEUTICAL : FDA Receives Paragraph IV Notice Letter for KUVAN(R) (..
09/23 BIOMARIN PHARMACEUTICAL : to Attend Upcoming Investor Conferences
09/16 Roche's $8 billion InterMune buy not a signal for more big deals
09/15 BIOMARIN PHARMACEUTICAL : Named by CenterWatch as One of the Fastest Developers ..
09/10 BIOMARIN PHARMACEUTICAL : Technical Coverage of Biotech Stocks - Dyax, Alexion P..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF